Trial Profile
Pharmacokinetics of S-1 in cancer patients with renal dysfunction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Fluorouracil
- Indications Cancer; Haematological malignancies; Solid tumours
- Focus Pharmacokinetics
- 28 Jan 2013 Status changed from not stated to completed as reported by University Hospital Medical Information Network - Japan record.
- 21 Sep 2011 New trial record